MiMedx Group, Inc. (MDXG) financial statements and ratios from SEC XBRL: revenue $418.63M (TTM), net margin 11.6%, revenue growth -34.7% YoY, P/E 100.3. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $418.63M |
| Net Margin | 11.6% |
| Revenue Growth (YoY) | -34.7% |
| EPS Growth (YoY) | -242.9% |
| P/E Ratio | 100.3 |
| EV / EBITDA | 21.6 |
| Price / Book | 2.89 |
| Price / Sales | 1.76 |
| DCF Value (model) | $7.89 |
| DCF Upside vs Price | 83.9% |
| Altman Z-Score | 6.85 (safe) |
| Piotroski F-Score | 5/9 |
| Sector P/E (Healthcare) | 21.6 |
MDXG overview · MDXG earnings · MDXG KPIs · MDXG investor relations · MDXG ownership · MDXG peers · MDXG filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.